(PBH, CRWE, THLD) CRWENewswire Stocks In Action
Threshold Pharmaceuticals Inc - THLD - reported Positive Phase 2b Clinical Trial Results of TH-302 in Patients With Pancreatic Cancer
21 Feb 2012
Threshold Pharmaceuticals Inc - THLD - reported Positive Phase 2b Clinical Trial Results of TH-302 in Patients With Pancreatic Cancer
21 Feb 2012
Comentários